Symbol: |
GLIPR2
|
Description: |
GLI pathogenesis-related 2 [Source:HGNC Symbol;Acc:18007]
|
Location: |
Chr9:36136730-36163910[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:235
Gene |
Compound |
Gen_sig |
Exp_pattern |
GLIPR2 |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.002 |
Down |
GLIPR2 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.001 |
Down |
GLIPR2 |
NSC 634398 |
0.006 |
Down |
GLIPR2 |
23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2-[3-methoxy-4-[1-oxo- 3-(dimethylamino)propoxy]cyclohexy |
0.007 |
Down |
GLIPR2 |
NSC 643836 |
0.024 |
Down |
GLIPR2 |
1,4-BIS(DIETHYLAMINO)-5,8-DIHYDROXY ANTHRAQUINON |
0.019 |
Down |
GLIPR2 |
Pyrimidine, 2-[1,5-bis(4-chlorophenyl)-1H-1,2,3-triazol-4-yl]- 1,4,5,6-tetrahydro- |
0.033 |
Up |
GLIPR2 |
2-Propen-1-one, 1-(4-chlorophenyl)-3-[4-[2-oxo- 2-(4-phenyl-1-piperazinyl)ethoxy]phenyl]-, (E)- |
0.001 |
Down |
GLIPR2 |
VIRIDENOMYCIN |
0.035 |
Down |
GLIPR2 |
NSC 648624 |
0.011 |
Down |
GLIPR2 |
3-Furancarbothioamide, [[3-(2-butenoxy)-4-methoxyphenyl]- 2-methyl- |
0.014 |
Down |
GLIPR2 |
NSC 651668 |
0.001 |
Down |
GLIPR2 |
NSC 658089 |
0.003 |
Down |
GLIPR2 |
NSC 658092 |
0.036 |
Down |
GLIPR2 |
2-(2-(Dimethylamino)ethylamino)naphthazarin |
0.015 |
Up |
Expression pattern: Sensitivity / Resistance
Total:16 Current:4
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:30
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|